Vaximm initiates phase I/II study of VXM-01 plus avelumab for the treatment of glioblastoma Dec. 17, 2018
Axovant licenses gene therapies for GM1 and GM2 gangliosidosis from University of Massachusetts Dec. 17, 2018
Novel class of antibacterial compounds targeting the LPS transport system of Gram-negative bacteria Dec. 17, 2018
RSS